✦ LIBER ✦

Resistance of recentNeisseria gonorrhoeaeisolates in nigeria and outcome of single-dose treatment with ciprofloxacin

✍ Scribed by J. A. M. Otubu; G. E. Imade; A. S. Sagay; O. A. Towobola; M. Phil

Book ID: 105285467
Publisher: Springer-Verlag
Year: 1992
Tongue: English
Weight: 544 KB
Volume: 20
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01710680

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of single-dose intraven

Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis

✍ Hiroshige Mikamo; Mochiyoshi Ninomiya; Teruhiko Tamaya 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 175 KB

A remarkable reduction in the susceptibi

A remarkable reduction in the susceptibility ofNeisseria gonorrhoeaeisolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan

✍ M. Tanaka; H. Nakayama; H. Tunoe; T. Egashira; A. Kanayama; T. Saika; I. Kobayas 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 99 KB

Histopathologic and clinical outcome of

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis

✍ Iva Gunnarsson; Birgitta Sundelin; Thorunn Jónsdóttir; Stefan H. Jacobson; Elisa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell–dependent diseases, including systemic lupus erythematosus (SLE). The purpose

A randomized comparative study of single

A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections

✍ Nurgul Ceran; Duygu Mert; Funda Yuksel Kocdogan; Ilknur Erdem; Riza Adalati; Sey 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 200 KB

Single nucleotide polymorphisms in the p

Single nucleotide polymorphisms in the promoter region of theIL1Bgene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib

✍ Annette J. Vangsted; Tobias W. Klausen; Niels Abildgaard; Niels F. Andersen; Pet 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 509 KB

Clinical outcome and pharmacokinetics af

Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: A case study of five patients with treatment-resistant inflammatory bowel disease

✍ Laurence J. Egan; Dr. William J. Tremaine; Dennis C. Mays; James J. Lipsky; Will 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 1 views